Correction to: Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Abstract:

:There was a mistake in Prof. Giuseppe Massimo Claudio Rosano's affiliation.

journal_name

Heart Fail Rev

journal_title

Heart failure reviews

authors

Mascolo A,Urbanek K,De Angelis A,Sessa M,Scavone C,Berrino L,Rosano GMC,Capuano A,Rossi F

doi

10.1007/s10741-020-10000-w

subject

Has Abstract

pub_date

2020-09-01 00:00:00

pages

897

issue

5

eissn

1382-4147

issn

1573-7322

pii

10.1007/s10741-020-10000-w

journal_volume

25

pub_type

已发布勘误
  • Angiotensin II and nitric oxide interaction.

    abstract::Nitric oxide degradation linked to endothelial dysfunction plays a central role in cardiovascular diseases. Superoxide producing enzymes such as NADPH oxidase and xanthine oxidase are responsible for NO degradation as they generate a variety of reactive oxygen species (ROS). Moreover, superoxide is rapidly degraded by...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1020714518246

    authors: de Gasparo M

    更新日期:2002-10-01 00:00:00

  • Expanded algorithm for managing patients with acute decompensated heart failure.

    abstract::Heart failure is a complex disease process, the manifestation of various cardiac and noncardiac abnormalities. General treatment approaches for heart failure have remained the same over the past decades despite the advent of novel therapies and monitoring modalities. In the same vein, the readmission rates for heart f...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9697-9

    authors: Njoroge JN,Cheema B,Ambrosy AP,Greene SJ,Collins SP,Vaduganathan M,Mebazaa A,Chioncel O,Butler J,Gheorghiade M

    更新日期:2018-07-01 00:00:00

  • Interactions between cytokines and neurohormonal systems in the failing heart.

    abstract::The prognosis for patients with congestive heart failure (CHF) has been improved as a result of the use of angiotensin converting enzyme inhibitors and beta-adrenergic receptor blockers. The success of these therapies underscores the pathogenic role of neurohormonal activation in CHF. Clinical and experimental evidenc...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1011405926588

    authors: Kan H,Finkel MS

    更新日期:2001-03-01 00:00:00

  • Mechanical circulatory support for elderly heart failure patients.

    abstract::End-stage systolic heart failure is an increasingly common problem in elderly patients and is associated with high cost, poor quality of life, and poor outcomes. Mechanical circulatory support is a promising therapy as both a bridge to transplantation and destination therapy. Elderly patients are frequently ineligible...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9298-y

    authors: Butler CR,Jugdutt BI

    更新日期:2012-09-01 00:00:00

  • In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

    abstract::To determine and address medication non-adherence is important and may improve patient outcomes. Our aim was to perform a systematic review on the operationalization of adherence measures in patients with heart failure using claims data. We searched the MEDLINE, EMBASE, and Cochrane databases. A quality check of the f...

    journal_title:Heart failure reviews

    pub_type: 杂志文章

    doi:10.1007/s10741-017-9656-x

    authors: Krueger K,Griese-Mammen N,Schubert I,Kieble M,Botermann L,Laufs U,Kloft C,Schulz M

    更新日期:2018-01-01 00:00:00

  • Pharmacological treatment of chronic heart failure.

    abstract::Heart failure (HF) is associated with a high morbidity and mortality in the Western World. Our knowledge of the epidemiology, pathophysiology, and therapy has improved dramatically during the last 20 years. Pharmacological treatment, as it stands today, is a combination of preventive and symptomatic strategies. The ma...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-006-9482-z

    authors: Adorisio R,De Luca L,Rossi J,Gheorghiade M

    更新日期:2006-06-01 00:00:00

  • How does the heart (not) die? The role of autophagy in cardiomyocyte homeostasis and cell death.

    abstract::Autophagy plays a critical and seemingly dual-purposed role in cardiomyocytes, being implicated as a mechanism of both cellular survival, for example, during ischemia/reperfusion injury and a mechanism of cell death at stages in which progressive myocyte alterations are beyond repair. This review aims to highlight the...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-009-9137-y

    authors: Dhesi P,Tehrani F,Fuess J,Schwarz ER

    更新日期:2010-01-01 00:00:00

  • Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects.

    abstract::Diabetes is a global epidemic and a leading cause of death with more than 422 million patients worldwide out of whom around 392 million alone suffer from type 2 diabetes (T2D). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are novel and effective drugs in managing glycemia of T2D patients. These inhibitors gained...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9665-9

    authors: Kaplan A,Abidi E,El-Yazbi A,Eid A,Booz GW,Zouein FA

    更新日期:2018-05-01 00:00:00

  • Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.

    abstract::Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, life-threatening disease characterized by deposition of insoluble amyloid fibrils in the myocardium, resulting in cardiac structural and functional abnormalities and ultimately heart failure. Disease frequency is reportedly lower in women than men, but s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10010-8

    authors: Bruno M,Castaño A,Burton A,Grodin JL

    更新日期:2021-01-01 00:00:00

  • Diabetes-related cardiovascular and economic burden in patients hospitalized for heart failure in the US: a recent temporal trend analysis from the National Inpatient Sample.

    abstract::We aimed to study the cardiovascular and economic burden of diabetes mellitus (DM) in patients hospitalized for heart failure (HF) in the US and to assess the recent temporal trend. Data from the National Inpatient Sample were analyzed between 2005 and 2014. The prevalence of DM increased from 40.4 to 46.5% in patient...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10012-6

    authors: Mekhaimar M,Dargham S,El-Shazly M,Al Suwaidi J,Jneid H,Abi Khalil C

    更新日期:2020-09-15 00:00:00

  • Anti-fibrotic effects of curcumin and some of its analogues in the heart.

    abstract::Cardiac fibrosis stems from the changes in the expression of fibrotic genes in cardiac fibroblasts (CFs) in response to the tissue damage induced by various cardiovascular diseases (CVDs) leading to their transformation into active myofibroblasts, which produce high amounts of extracellular matrix (ECM) proteins leadi...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09854-6

    authors: Gorabi AM,Hajighasemi S,Kiaie N,Rosano GMC,Sathyapalan T,Al-Rasadi K,Sahebkar A

    更新日期:2020-09-01 00:00:00

  • Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease.

    abstract::Important changes occur in the cardiovascular system with advancing age, even in apparently healthy individuals. Thickening and stiffening of the large arteries develop due to collagen and calcium deposition and loss of elastic fibers in the medial layer. These arterial changes cause systolic blood pressure to rise wi...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9270-2

    authors: Fleg JL,Strait J

    更新日期:2012-09-01 00:00:00

  • Biomarkers of inflammation in heart failure.

    abstract::Heart failure (HF) is characterized by the elaboration of a portfolio of pro-inflammatory cytokines and inflammatory mediators that are considered to contribute to disease progression by virtue of the deleterious effects that these molecules exert on the heart and circulation. Recent studies have suggested that these ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-009-9140-3

    authors: Bozkurt B,Mann DL,Deswal A

    更新日期:2010-07-01 00:00:00

  • Preconditioning in humans.

    abstract::Brief ischemia to the myocardium initiates a cascade of biochemical events in cardiac myocytes that protects the heart muscle during subsequent ischemic insults. This phenomenon is called ischemic preconditioning. If an acute myocardial infarction is preceded by preinfarction angina, it results in smaller infarction s...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9037-y

    authors: Rezkalla SH,Kloner RA

    更新日期:2007-12-01 00:00:00

  • Definition, epidemiology and registries of pulmonary hypertension.

    abstract::Pulmonary arterial hypertension (PAH) is a subcategory of pulmonary hypertension (PH) that comprises a group of disorders with similar pulmonary vascular pathology. Though PH is common, the estimated incidence of IPAH is 1-3 cases per million, making it a rare disease. The hemodynamic definition of PAH is a mean pulmo...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-015-9510-y

    authors: Awdish R,Cajigas H

    更新日期:2016-05-01 00:00:00

  • Sarcomeric proteins in hypertrophied and failing myocardium: an overview.

    abstract::This collection of papers covers developments in a rapidly growing area, sarcomeric proteins in hypertrophied and failing myocardium. Advances in our understanding of the biochemistry and biophysics of crossbridge cycling, contributions of thick versus thin filament and the emerging role of titin, the importance and m...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-005-5247-3

    authors: LeWinter MM,VanBuren P

    更新日期:2005-09-01 00:00:00

  • Interdisciplinary approach to compensation of hypoglycemia in diabetic patients with chronic heart failure.

    abstract::Diabetes mellitus is a chronic disease requiring lifelong control with hypoglycemic agents that must demonstrate excellent efficacy and safety profiles. In patients taking glucose-lowering drugs, hypoglycemia is a common cause of death associated with arrhythmias, increased thrombus formation, and specific effects of ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9647-y

    authors: Anfinogenova Y,Grakova EV,Shvedova M,Kopieva KV,Teplyakov AT,Popov SV

    更新日期:2018-05-01 00:00:00

  • Biomarkers in heart failure: a clinical review.

    abstract::The diagnosis and management of heart failure remains challenging despite considerable clinical advances in recent decades. With greater understanding of the pathophysiology of this complex syndrome, a large number of candidate biomarkers have emerged and duly received scientific and clinical attention. These are freq...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9123-9

    authors: Rocchiccioli JP,McMurray JJ,Dominiczak AF

    更新日期:2010-07-01 00:00:00

  • Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes.

    abstract::Genomic mechanisms of mineralocorticoid action have been increasingly elucidated over the past four decades. In renal epithelia, the main effect is an increase in sodium transport through activation and de novo synthesis of epithelial sodium channels. This leads to increased concentrations of intracellular sodium acti...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-005-2347-z

    authors: Wehling M

    更新日期:2005-01-01 00:00:00

  • Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions.

    abstract::Heart failure is a complex clinical syndrome associated with a significant morbidity and mortality burden. Reductions in left ventricular (LV) function trigger adaptive mechanisms, leading to structural changes within the LV and the potential development of dyssynchronous ventricular activation. This is the substrate ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9734-8

    authors: Sieniewicz BJ,Gould J,Porter B,Sidhu BS,Teall T,Webb J,Carr-White G,Rinaldi CA

    更新日期:2019-01-01 00:00:00

  • Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.

    abstract::Obstructive sleep apnea (OSA) is increasingly recognized as a novel cardiovascular risk factor. OSA is implicated in the pathogenesis of hypertension, left ventricular dysfunction, coronary artery disease and stroke. OSA exerts its negative cardiovascular consequences through its unique pattern of intermittent hypoxia...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9112-z

    authors: Khayat R,Patt B,Hayes D Jr

    更新日期:2009-09-01 00:00:00

  • Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.

    abstract::Chronic obstructive pulmonary disease (COPD) is a major health problem worldwide, with co-morbidities contributing to the overall severity and mortality of the disease. The incidence and prevalence of cardiovascular disease among COPD patients are high. Both disorders often co-exist, mainly due to smoking, but they al...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9646-z

    authors: Petta V,Perlikos F,Loukides S,Bakakos P,Chalkias A,Iacovidou N,Xanthos T,Tsekoura D,Hillas G

    更新日期:2017-11-01 00:00:00

  • Therapeutic role of bosentan in hypertension: lessons from the model of perinephritic hypertension.

    abstract::Since its discovery in 1988, there has been increasing evidence that endothelin-1 (ET-1) plays an important role in the pathophysiology of hypertension and its related end-organ damages. First studies, using ET-1 administration in animals or in humans suspected this role by demonstrating the hypertensive properties of...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1011419223152

    authors: Donckier JE

    更新日期:2001-12-01 00:00:00

  • Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome.

    abstract:BACKGROUND:Transient left ventricular apical ballooning syndrome also called Tako-Tsubo cardiomyopathy is defined as a syndrome consisting of stress induced apical ballooning of the left ventricle and normal coronary arteries. The majority of the published reports are case reports or case series with a small number of ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,meta分析

    doi:10.1007/s10741-005-8555-8

    authors: Donohue D,Movahed MR

    更新日期:2005-12-01 00:00:00

  • Long non-coding RNAs in cardiac hypertrophy.

    abstract::Cardiac hypertrophy (CH) is generally considered adaptive responses that may occur after myocardial infarction, pressure overload, volume overload, inflammatory heart muscle disease, or idiopathic dilated cardiomyopathy, whereas long-term stimulation eventually leads to heart failure (HF). However, the current molecul...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09882-2

    authors: Sun J,Wang C

    更新日期:2020-11-01 00:00:00

  • Effects of apelin on the cardiovascular system.

    abstract::Apelin is an endogenous peptide acting on the APJ receptor. It consists of several isoforms characterized by different numbers of amino acids. The number of amino acids in the active isoforms range from 36 to 12. Apelin-13 and, to a lesser extent, apelin-36 are considered the most active isoforms with the greatest act...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-015-9475-x

    authors: Folino A,Montarolo PG,Samaja M,Rastaldo R

    更新日期:2015-07-01 00:00:00

  • Protective molecular mechanisms of clusterin against apoptosis in cardiomyocytes.

    abstract::Loss of cardiomyocytes occurs with aging and contributes to cardiovascular complications. In the present study, we highlighted the role of clusterin, a protein that has recently been associated with the protection of cardiomyocytes from apoptosis. Clusterin protects cardiac cells against damage from myocardial infarct...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9654-z

    authors: Pereira RM,Mekary RA,da Cruz Rodrigues KC,Anaruma CP,Ropelle ER,da Silva ASR,Cintra DE,Pauli JR,de Moura LP

    更新日期:2018-01-01 00:00:00

  • Personalised computational cardiology: Patient-specific modelling in cardiac mechanics and biomaterial injection therapies for myocardial infarction.

    abstract::Predictive computational modelling in biomedical research offers the potential to integrate diverse data, uncover biological mechanisms that are not easily accessible through experimental methods and expose gaps in knowledge requiring further research. Recent developments in computing and diagnostic technologies have ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-016-9528-9

    authors: Sack KL,Davies NH,Guccione JM,Franz T

    更新日期:2016-11-01 00:00:00

  • Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction.

    abstract::This study aimed to evaluate the diagnostic performance of echocardiographic markers of heart failure with preserved ejection fraction (HFpEF) and left ventricular diastolic dysfunction (LVDD) in comparison with the gold standard of cardiac catheterization. Diagnosing HFpEF is challenging, as symptoms are non-specific...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09985-1

    authors: Dal Canto E,Remmelzwaal S,van Ballegooijen AJ,Handoko ML,Heymans S,van Empel V,Paulus WJ,Nijpels G,Elders P,Beulens JW

    更新日期:2020-06-02 00:00:00

  • Is there a blood pressure lowering effect of MRAs in heart failure? An overview and meta-analysis.

    abstract::Although mineralocorticoid antagonists (MRAs) have been proposed as effective fourth-line blood pressure (BP) lowering agents in resistant hypertension, this effect in heart failure is undetermined. In this synthesis of heart failure randomized controlled trials (RCTs), we evaluated the extent of BP lowering following...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s10741-018-9689-9

    authors: Bazoukis G,Thomopoulos C,Tse G,Tsioufis C

    更新日期:2018-07-01 00:00:00